Brand prescription drugs to rise an average 4.5 percent in 2025
| IVITX Fund | USD 22.41 0.22 0.99% |
Slightly above 50% of Vy(r) Invesco's investors are presently thinking to get in. The analysis of overall sentiment of trading Vy Invesco Growth mutual fund suggests that some investors are interested at this time. Vy(r) Invesco's investing sentiment can be driven by a variety of factors including economic data, Vy(r) Invesco's earnings reports, geopolitical events, and overall market trends.
Vy(r) |
Branded prescription drug prices set to rise by 4.5 percent in 2025, with Pfizer, Bristol Myers Squibb, Sanofi, and Merck making price adjustments.
Read at seekingalpha.com
 |
Vy(r) Invesco Fundamental Analysis
We analyze Vy(r) Invesco's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vy(r) Invesco using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vy(r) Invesco based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Vy Invesco is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Vy Invesco Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vy(r) Invesco mutual fund to make a market-neutral strategy. Peer analysis of Vy(r) Invesco could also be used in its relative valuation, which is a method of valuing Vy(r) Invesco by comparing valuation metrics with similar companies.
Peers
Vy(r) Invesco Related Equities
| PASTX | T Rowe | 1.78 | ||||
| SEHAX | Siit Us | 1.11 | ||||
| SMYIX | Qs Global | 1.07 | ||||
| AUUIX | Ab Select | 0.97 | ||||
| FREIX | Franklin Equity | 0.77 | ||||
| GMADX | Gmo Global | 0.61 | ||||
| GTLSX | Quantitative Longshort | 0.37 |
Other Information on Investing in Vy(r) Mutual Fund
Vy(r) Invesco financial ratios help investors to determine whether Vy(r) Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vy(r) with respect to the benefits of owning Vy(r) Invesco security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |